Chronic Myeloid Leukemia Market Outlook 2025-2035: The 7 major chronic myeloid leukemia market reached a value of USD 5.7 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 8.9 ...
Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.
Suboptimal response or treatment failure to standard-dose imatinib are relevant problems in chronic-phase chronic myeloid leukemia patients. Insufficient adherence is one of the main causes of ...
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...
Harvey Weinstein, who has been hospitalized for various health issues over the years, told a judge he doesn't "know how much longer I can hold on." ...